These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2006-001530-40||Vascular targeted photodynamic therapy using WST09 for patients with untreated localised prostate cancer - Repeat procedure – Phase IIa, Single centre, open-label study.||2008-10-17||due-trials|
|Ongoing||2008-000876-26||"VASCULAR-TARGETED PHOTODYNAMIC THERAPY USING WST11 IN PATIENTS WITH LOCALISED PROSTATE CANCE"||not-yet-due|
|Ongoing||2009-011895-31||EVALUATION OF THE SAFETY AND EFFICACY OF WST11 MEDIATED VASCULAR TARGETED PHOTODYNAMIC THERAPY ON OBSTRUCTING ENDOBRONCHIAL NON-SMALL CELL LUNG CANCER||not-yet-due|
|Ongoing||2009-011897-14||EVALUATION OF THE SAFETY AND EFFICACY OF WST11-MEDIATED VASCULAR TARGETED PHOTODYNAMIC THERAPY ON NON-RESECTABLE OR INOPERABLE CHOLANGIOCARCINOMA||not-yet-due|
|Ongoing||2009-012809-19||VASCULAR-TARGETED PHOTODYNAMIC THERAPY USING WST11 IN PATIENTS WITH LOCALISED PROSTATE CANCER||not-yet-due|
|Ongoing||2009-017435-18||A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Relate...||not-yet-due|
|Listed as ongoing, but also has a completion date||2010-021900-93||A European randomised Phase 3 study to assess the efficacy and safety of TOOKAD® Soluble for localised prostate cancer compared to Active Surveillance||2015-06-25||bad-data|